Search Results - "Susekov, A. V."

Rationale for Increasing Doses of Statins in Everyday Clinical Practice by Susekov, A V

“…HMG-CoA reductase inhibitors (statins) were discovered in the early 1970s in Japan and were originally used to treat patients with hereditary hyperlipidemia…”
Get more information

Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin by Susekov, A V

“…Administration of high doses of atorvastatin 80 mg/day and rosuvastatin 40 mg/day is a part of a standard algorithm for the treatment of patients at high and…”
Get more information

Modern algorithms for statin therapy by Susekov, V. A.

“…HMG-CoA reductase inhibitors (statins) are a key class of drugs for the treatment and prevention of atherosclerosis and its complications. This class of drugs…”
Get full text

Statin-induced rhabdomyolysis in a 60-year-old woman with decompensated type 2 diabetes: a case report by Tsygankova, O. V., Evdokimova, N. E., Bayramova, S. S., Susekov, A. V.

“…Rhabdomyolysis is a very rare and most severe form of statin-induced muscle adverse event characterized by muscle pain, muscle necrosis with myoglobinemia…”
Get full text

Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later by Susekov, A V, Gorniakova, N B, Zubareva, M Iu

“…The review describes the history of hypolipidemic therapy with statins. It gives the results of studies of the primary prevention of atherosclerosis and the…”
Get full text

Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts by Kobalava, J D, Gurevich, V S, Galyavich, A M, Kaminnyi, A I, Kashtalap, V V, Mareev, V Yu, Susekov, A V, Shaposhnik, I I

“…This Conclusion of the Board of experts is devoted to the analysis of the evidence base, the position in modern clinical guidelines, the efficacy and safety…”
Get more information

Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment by V. К. Zafiraki, Е. D. Kosmacheva, I. N. Zakharova, V. A. Korneva, A. V. Susekov

“…Homozygous familial hypercholesterolemia is a rare genetic disease featuring extremely high of low-density lipoprotein blood level, cutaneous and tendon…”
Get full text

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY by Susekov, A. V., Bulatov, V. A., Vigdorchik, A. V.

“…Aim. To evaluate quality of life changes and compliance to therapy in patients following successful transluminal angioplasty, who have indications for…”
Get full text

Statin therapy and atherosclerosis stabilization in carotid arteries by Luginova, Z. G, Koshurnikova, M. V, Solovieva, E. Yu, Balakhonova, T. V, Susekov, A. V

“…Atherosclerosis and it’s clinical implications (myocardial infarction, stroke, intermittent lameness) is a serious medico-social problem in Russia. Statins (or…”
Get full text

Atorvastatin: evidence base 15 years later by Susekov, A. V., Khokhlova, N. V.

“…HMG-CoA inhibitors have been widely used in primary and secondary prevention of atherosclerosis for more than 30 years. The evidence base for statins includes…”
Get full text

Perspectives of the use of fenofibrate in patients with type 2 diabetes mellitus: what is new after the ACCORD Study? by Susekov, A V, Khokhlova, N V

Get more information

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study) by Oganov, R. G., Kukharchuk, V. V., Arutyunov, G. P., Galyavich, A. S., Gurevich, V. S., Duplyakov, D. V., Karpov, Yu. A., Kobalava, Zh. D., Konstantinov, V. O., Martsevich, S. Yu, Panov, A. V., Sergienko, I. V., Skibitskyi, V. V., Smolenskaya, O. G., Susekov, A. V., Tyurin, V. P., Shalaev, S. V., Maneshina, O. A., Brigida, O. V.

“…The high prevalence of persistent dyslipidemia in primary and specialized care patients treated with statins justifies the need to identify its reasons and…”
Get full text

Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia by Susekov, A V

Get more information

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE by Susekov, A. V., Khokhlova, N. V.

“…The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy of atorvastatin is demonstrated in according to comparative…”
Get full text

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia by M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva, A. V. Susekov

“…Aim. To study the lipid-lowering effectiveness, as well as the effects on inflammatory markers and vascular wall function, of ezetimibe as monotherapy and in…”
Get full text

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines by Susekov, A. V., Zubareva, M. Yu, Rozhkova, T. A., Masenko, V. P.

“…Aim. To assess the effects of original statins as monotherapy or in combination with ezetimibe on the levels of proinflammatory cytokines and high-sensitive…”
Get full text

STATINS IN PREVENTION OF ISCHEMIC STROKE by Susekov, A. V., Blohin, A. B., Luginova, Z. G., Soloveva, E. J., Maltseva, N. V., Tarasova, O. E., Kuharchuk, V. V.

“…The evidence base of statin therapy in primary and secondary prevention of ischemic stroke is surveyed. Results of classical trails with statins in ischemic…”
Get full text

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY by Susekov, A. V., Bulatov, V. A., Vigdorchik, A. V.

“…Aim. The main aim of the present study was to evaluate quality of life changes and compliance to therapy in patients following successful transluminal…”
Get full text

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis by A. V. Susekov, N. B. Gornyakova, M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva

“…The increased level of low-density lipoprotein cholesterol (LDL-CH) is one of the risk factors (RFs) of coronary heart disease and atherosclerosis. Statins,…”
Get full text

P2.05 Arterial Wall Function in Patients with Coronary Heart Disease and Dyslipidemia, Comparative Efficacy of Ezetimibe, Statins and Their Combination by Tripoten, M. I., Pogorelova, O. A., Zubareva, M. Y., Kukharchuk, V. V., Rogoza, A. N., Susekov, A. V., Balakhonova, T. V.

“…Purpose The aim of this study was to compare efficacy of treatment by ezetimibe (EZ), starting doses of statins and their combination on lipids and arterial…”
Get full text